At Glyphic Biotechnologies, we plan to create the protein revolution for which scientists and researchers have been waiting. We are developing a massively parallel, single-molecule proteome sequencing platform that will transform life science discovery and usher in a new era of insights into human biology and disease. To date, we have raised >$80M from venture partners and non-dilutive grant funding to achieve our vision of next generation proteome sequencing.
- Founded
- 2021
- Company size
- 11-50
- Headquarters
- Berkeley, California, US
- Funding
- Seed
Hiring activity
- Open roles
- 2
- Posted in the last 30 days
- 2
Updated 7h ago
Latest openings
2 open roles at Glyphic Biotechnologies. Members see each one.